Table 4.
Summary of patients who developed recurrent epidural disease.
| Case | Histopathology | Site | Prescribed dose | Minimum dose (%) | Mean dose (%) | Max dose (%) | Time to recurrence (months) | Max distance between the 95% isodose line and the inner target (mm) |
|---|---|---|---|---|---|---|---|---|
| 1 | NSCLC | Thoracic | 27Gy/3fx | 51 | 104 | 116 | 5 | 5 |
| 2 | Prostate | Thoracic | 27Gy/3fx | 72 | 105 | 117 | 6 | 2 |
| 3 | RCC | Thoracic | 27Gy/3fx | 76 | 104 | 111 | 12 | 4 |
| 4 | Cholangiocarcinoma | Lumbar | 18Gy/1fx | 85 | 103 | 111 | 1 | 3 |
| 5 | Colorectal | Lumbar | 27Gy/3fx | 51 | 105 | 113 | 14 | 6 |
NSCLC, non-small cell lung cancer; RCC, renal cell carcinoma; Gy, Gray; Fx, fraction.